INVO Fertility, Inc. — Form S-1
Filed July 24, 2026 · analyzed by the Registration Agent
S-1
▼ Likely negative
significance 72/100
What the filing says
On July 24, 2026, INVO Fertility (public market cap ~$2.2M) entered an Any Market Purchase Agreement with Alumni Capital LP permitting INVO to sell up to 20,000,000 shares (representing ~89.7% of current outstanding shares if all issued) for up to $15M gross proceeds (expandable to $50M by mutual agreement). Alumni will resell shares at market prices; INVO receives no proceeds from Alumni's resales. INVO pays 1% commitment fee and controls timing/amount of sales to Alumni. Additionally, INVO completed acquisition of HRCFG (Birmingham fertility clinic) for $175,001 ($1 cash at closing, $48K over 9 months, $127K from free cash flow) on June 23, 2026.
Why this rating
Massive dilution event—up to 89.7% share issuance potential is material to tiny $2.2M company. Extreme downward pressure risk and financing desperation signal.
See more from July 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.